Monoclonal antibody specific for lactosylceramide

J Biol Chem. 1984 May 10;259(9):6008-12.


The mouse hybridoma line T5A7 was derived during studies aimed at mapping human myeloid differentiation antigens. The IgM antibody secreted by this line recognizes an antigen richly expressed on mature myelomonocytic cells and on a subpopulation of lectin-activated human T-lymphocytes (Andrews, R. G., Torok-Storb, B., and Bernstein, I. D. (1983) Blood 62, 124-132). In the present study, we have determined the specificity of T5A7 antibody to be directed to lactosylceramide (Gal beta 1----4Glc beta 1----1 Cer) based on direct and indirect binding assays using a variety of glycolipids with known structures. The antibody did not cross-react with glycolipids having an N-acetyllactosamine terminus, including lactoneotetraosylceramide lactonorhexaosylceramide (i antigen), and lactoisooctaosylceramide (I antigen). The possible contribution of ceramide to the reactivity of lactosylceramide with this antibody was also studied using lactosylceramide preparations having different fatty acid composition.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal*
  • Antigen-Antibody Complex
  • Antigens, CD*
  • Carbohydrates
  • Cell Line
  • Glycolipids / isolation & purification
  • Glycosphingolipids / analysis*
  • Humans
  • Hybridomas / immunology
  • Lactosylceramides*
  • Leukemia, Myeloid, Acute
  • Mice
  • Radioimmunoassay


  • Antibodies, Monoclonal
  • Antigen-Antibody Complex
  • Antigens, CD
  • Carbohydrates
  • Glycolipids
  • Glycosphingolipids
  • Lactosylceramides
  • CDw17 antigen